Annual Non Current Assets
$264.00 M
-$14.00 M-5.04%
31 December 2023
Summary:
Arcus Biosciences annual long term assets is currently $264.00 million, with the most recent change of -$14.00 million (-5.04%) on 31 December 2023. During the last 3 years, it has risen by +$227.52 million (+623.74%). RCUS annual non current assets is now -20.00% below its all-time high of $330.00 million, reached on 31 December 2021.RCUS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$125.00 M
-$39.00 M-23.78%
30 September 2024
Summary:
Arcus Biosciences quarterly long term assets is currently $125.00 million, with the most recent change of -$39.00 million (-23.78%) on 30 September 2024. Over the past year, it has dropped by -$184.00 million (-59.55%). RCUS quarterly non current assets is now -62.12% below its all-time high of $330.00 million, reached on 31 December 2021.RCUS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.0% | -59.5% |
3 y3 years | +623.7% | -57.5% |
5 y5 years | +1552.4% | +659.0% |
RCUS Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -20.0% | +623.7% | -62.1% | at low |
5 y | 5 years | -20.0% | +2437.2% | -62.1% | +1176.8% |
alltime | all time | -20.0% | +2537.1% | -62.1% | +1176.8% |
Arcus Biosciences Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $125.00 M(-23.8%) |
June 2024 | - | $164.00 M(-28.4%) |
Mar 2024 | - | $229.00 M(-13.3%) |
Dec 2023 | $831.00 M(-22.1%) | $264.00 M(-14.6%) |
Sept 2023 | - | $309.00 M(+32.1%) |
June 2023 | - | $234.00 M(-2.1%) |
Mar 2023 | - | $239.00 M(-14.0%) |
Dec 2022 | $1.07 B(-15.5%) | $278.00 M(-5.0%) |
Sept 2022 | - | $292.71 M(+17.4%) |
June 2022 | - | $249.30 M(-10.7%) |
Mar 2022 | - | $279.20 M(-15.4%) |
Dec 2021 | $1.26 B | $330.00 M(+12.2%) |
Sept 2021 | - | $294.00 M(+92.4%) |
June 2021 | - | $152.82 M(+63.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $93.25 M(+155.6%) |
Dec 2020 | $735.82 M(+281.8%) | $36.48 M(+162.9%) |
Sept 2020 | - | $13.88 M(+41.7%) |
June 2020 | - | $9.79 M(-1.4%) |
Mar 2020 | - | $9.93 M(-4.6%) |
Dec 2019 | $192.71 M(-25.6%) | $10.40 M(-36.8%) |
Sept 2019 | - | $16.47 M(+46.5%) |
June 2019 | - | $11.24 M(-16.8%) |
Mar 2019 | - | $13.52 M(-15.4%) |
Dec 2018 | $258.95 M(+46.4%) | $15.98 M(-25.5%) |
Sept 2018 | - | $21.44 M(-18.9%) |
June 2018 | - | $26.42 M(+13.3%) |
Mar 2018 | - | $23.33 M(+71.3%) |
Dec 2017 | $176.87 M(+77.4%) | $13.62 M |
Dec 2016 | $99.69 M | - |
FAQ
- What is Arcus Biosciences annual long term assets?
- What is the all time high annual non current assets for Arcus Biosciences?
- What is Arcus Biosciences annual non current assets year-on-year change?
- What is Arcus Biosciences quarterly long term assets?
- What is the all time high quarterly non current assets for Arcus Biosciences?
- What is Arcus Biosciences quarterly non current assets year-on-year change?
What is Arcus Biosciences annual long term assets?
The current annual non current assets of RCUS is $264.00 M
What is the all time high annual non current assets for Arcus Biosciences?
Arcus Biosciences all-time high annual long term assets is $330.00 M
What is Arcus Biosciences annual non current assets year-on-year change?
Over the past year, RCUS annual long term assets has changed by -$14.00 M (-5.04%)
What is Arcus Biosciences quarterly long term assets?
The current quarterly non current assets of RCUS is $125.00 M
What is the all time high quarterly non current assets for Arcus Biosciences?
Arcus Biosciences all-time high quarterly long term assets is $330.00 M
What is Arcus Biosciences quarterly non current assets year-on-year change?
Over the past year, RCUS quarterly long term assets has changed by -$184.00 M (-59.55%)